Optas, LLC Moderna, Inc. Transaction History

Optas, LLC

  • $361 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$225.82 - $368.51 $219,045 - $357,454
-970 Closed
0 $0
Q3 2021

Oct 14, 2021
SELL
$221.9 - $484.47 $23,077 - $50,384
-104 Reduced 9.68%
970 $373,000
Q2 2021

Jul 27, 2021
BUY
$129.91 - $234.98 $139,523 - $252,368
1,074 New
1,074 $252,000

Others Institutions Holding MRNA

# of Institutions
1,038
Shares Held
245M
Call Options Held
12.1M
Put Options Held
9.36M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Optas, LLC Portfolio

Follow Optas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email